c-KIT-mediated growth and survival may be prevented by overexpressing PP2A-Aα in myeloid c-KIT+ cells, suggesting that restoration of PP2A activity in c-KIT+ AML patients may represent a good therapeutic strategy to overcome drug resistance (29). This evidence concerns the gene KIT and acute myeloid leukemia.